These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20083608)

  • 41. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-protein coupled receptors as allosteric machines.
    Kenakin T
    Recept Channels; 2004; 10(2):51-60. PubMed ID: 15204035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.
    Burgmer U; Schulz U; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):363-70. PubMed ID: 9606020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BRET- and fluorescence anisotropy-based assays for real-time monitoring of ligand binding to M
    Grätz L; Laasfeld T; Allikalt A; Gruber CG; Pegoli A; Tahk MJ; Tsernant ML; Keller M; Rinken A
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118930. PubMed ID: 33347921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
    Thomas RL; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments.
    Peter JC; Wallukat G; Tugler J; Maurice D; Roegel JC; Briand JP; Hoebeke J
    J Biol Chem; 2004 Dec; 279(53):55697-706. PubMed ID: 15485827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of acetylcholine mustard to study allosteric interactions at the M(2) muscarinic receptor.
    Suga H; Figueroa KW; Ehlert FJ
    J Pharmacol Exp Ther; 2008 Nov; 327(2):518-28. PubMed ID: 18682569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visualization of the activation of the histamine H3 receptor (H3R) using novel fluorescence resonance energy transfer biosensors and their potential application to the study of H3R pharmacology.
    Liu Y; Zeng H; Pediani JD; Ward RJ; Chen LY; Wu N; Ma L; Tang M; Yang Y; An S; Guo XX; Hao Q; Xu TR
    FEBS J; 2018 Jun; 285(12):2319-2336. PubMed ID: 29701013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.
    Gnagey AL; Seidenberg M; Ellis J
    Mol Pharmacol; 1999 Dec; 56(6):1245-53. PubMed ID: 10570052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.
    Hoffmann C; Gaietta G; Bünemann M; Adams SR; Oberdorff-Maass S; Behr B; Vilardaga JP; Tsien RY; Ellisman MH; Lohse MJ
    Nat Methods; 2005 Mar; 2(3):171-6. PubMed ID: 15782185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allosteric interactions at muscarinic cholinoceptors.
    Christopoulos A; Lanzafame A; Mitchelson F
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):185-94. PubMed ID: 9590567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor.
    Bock A; Bermudez M; Krebs F; Matera C; Chirinda B; Sydow D; Dallanoce C; Holzgrabe U; De Amici M; Lohse MJ; Wolber G; Mohr K
    J Biol Chem; 2016 Jul; 291(31):16375-89. PubMed ID: 27298318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.
    Elsinghorst PW; Cieslik JS; Mohr K; Tränkle C; Gütschow M
    J Med Chem; 2007 Nov; 50(23):5685-95. PubMed ID: 17944454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
    Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allostery of atypical modulators at oligomeric G protein-coupled receptors.
    Shivnaraine RV; Kelly B; Elmslie G; Huang XP; Dong YJ; Seidenberg M; Wells JW; Ellis J
    Sci Rep; 2021 Apr; 11(1):9265. PubMed ID: 33927236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.